Literature DB >> 10350207

Cerebellar ataxia following whooping cough.

F Setta1, M Baecke, J Jacquy, J Hildebrand, G Monseu, M U Manto.   

Abstract

Bordetella pertussis (BP), the agent of whooping cough, has not been recognized so far as a cause of permanent cerebellar ataxia in human. We describe three patients who developed a disabling and permanent cerebellar syndrome soon after whooping cough. In two patients, diagnosis of BP infection was confirmed by culture of nasopharyngeal secretions. The infection occurred between the age of 13 and 15 years, with neurological symptoms beginning after a delay varying from 3 weeks to 3 months. In our three patients, the cerebellar syndrome was characterized by dysmetria of ocular saccades, scanning speech and ataxic gait. Brain MRI demonstrated a pancerebellar atrophy. The pathogenesis of this cerebellar degeneration is not established. Experimental studies have demonstrated that the cerebellum is particularly vulnerable to lymphocytosis-promoting factor (LPF), one of the exotoxins from BP. The mechanism of this toxicity might be a marked increase in the cellular levels of 3',5'cyclic guanosine monophosphate (cGMP). Since whooping cough is a bacterial exotoxin-mediated disease, this is the first report of a cerebellar syndrome triggered by a bacterial exotoxin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10350207     DOI: 10.1016/s0303-8467(99)00004-9

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  2 in total

Review 1.  Tremor-spectrum in spinocerebellar ataxia type 3.

Authors:  Cecilia Bonnet; Emmanuelle Apartis; Mathieu Anheim; Andre P Legrand; Jose F Baizabal-Carvallo; Anne M Bonnet; Alexandra Durr; Marie Vidailhet
Journal:  J Neurol       Date:  2012-05-17       Impact factor: 4.849

2.  Collaborative pediatric critical care research network: looking back and moving forward.

Authors:  Douglas F Willson; J Michael Dean; Kathleen L Meert; Christopher J L Newth; Kanwaljeet J S Anand; John Berger; Rick Harrison; Jerry Zimmerman; Joseph Carcillo; Murray Pollack; Richard Holubkov; Tammara L Jenkins; Carol Nicholson
Journal:  Pediatr Crit Care Med       Date:  2010-01       Impact factor: 3.624

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.